Prof. Dr.

Hakan Büyükhatipoğlu

Tıbbi Onkoloji

İlgi Alanları

•    Meme kanseri
•    Moleküler onkoloji ve hedefe yönelik tedaviler
•    İmmünoterapi
•    Akciğer, Kolon, Mide, Pankreas, Over, Endometrium, Serviks, Mesane, Prostat, Testis, lenfomalar ve diğer kanserler
•    İleri evre kanserlerde HIPEC (ısıtılmış kemoterapi) tedavileri

 

Eğitim ve Deneyim
•    Liv Hastanesi Tıbbı Onkoloji Kliniği (2021)
•    Master of Molecular Oncology (2019-2010)
•    Harran Üniversitesi Öğretim Üyesi Prof. (2020)
•    Özel Adana Hastanesi (2019)
•    Harran Üniversitesi Doç.-Prof. (2015-2018)
•    European Institute of Oncology Clinical Research Fellowship, Milan (2014)
•    Gaziantep Üniversitesi Doç. (2012-2015)
•    MD. Anderson Cancer Center (2010)
•    Bozova Devlet hastanesi mecburi hizmet (2008-2010)
•    Gaziantep Üniversitesi Asistan. Dr. (2002-2007)
•    Ankara Üniversitesi Tıp fakültesi (1993-2000)
•    Gaziantep Anadolu Lisesi (1986-1993)

 
•    Uluslararası
1.    Kirhan I, Kas F, Taskiran H,Buyukhatipoglu H, Gonel A, Koyuncu I. Evaluation of micro-RNA levels, apoptosis and oxidative stress markers in patients receiving chemotherapy. Comb Chem Throughout Screen 2020; 1: 17-27. 
2.    Suner A, Buyukhatipoglu H, ve ark. Polymorphisms in the MTHFR gene are associated with recurrence risk in lymhp node-positive breast cancer patients. Onco Targets Ther 2016; 9: 5603-9.
3.    Sarici F, Babacan T, Buyukhatipoglu H, ve ark. Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience. J BUON 2016; 21: 826-31.
4.    Akal A, Ulas T, Goncu T, Guldur ME, Kocarslan S, Taskin A, Sezen H, Ozkan K, Yilmaz OF, Buyukhatipoglu H. Evaluating the safety of intracameral bevacizumab application using oxidative stress and apoptotic parameters in corneal tissue. Int J Ophthalmol 2015; 8: 697-702.
5.    Babacan T, Efe O, Hasirci AS, Demirci F, Buyukhatipoglu H, ve ark. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer. Tumori 2015; 101: 418-23.
6.    Yumrutas O, Oztuzcu S, Buyukhatipoglu H, ve ark. The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer. Tumour Biol 2015;36:4427-32.
7.    Turkmen S, Buyukhatipoglu H, Suner A, Ulas T. Prior cholecystectomy predisposes to acute pancreatitis in codeine-prescribed patients. International journal of critical illness and Injury science. Int J Crit Illn Inj Sci 2015; 2: 114-5.
8.    Babacan T, Buyukhatipoglu H, Balakan O, ve ark. Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER-2 negative breast cancer patients: a long-term retrospective analysis. J BUON 2015; 20: 479-86.
9.    Buyukhatipoglu H, Babacan T, Kertmen N, et al. A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer.  J BUON 2015; 1: 22-27
10.    Ulas T, Karakas EY, Bes C, Borlu F, Buyukhatipoglu H. Hepatosplenomegaly and pernicious anaemia. J Clin Diagn Res 2014; 12: ML01
11.    Demir ME, Ercan Z, Karakas EY, Ulas T, Buyukhatipoglu H. Crohnic kidney disease: recurrent acute kidney failure in a patient with Crohn’s disease. N Am J Med Sci 2014; 6: 648-9.
12.    Kalender ME, Buyukhatipoglu H, Balakan O, Suner A, Dirier A, Sevinc A, Bulbul F, Tatli MA, Ulas T, Camci C. Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey. Journal of Cancer Research and Therapeutics 2014;10:962
13.    Demir M, Ulas T, Tutoglu A, Boyaci A, Karakas EY, Sezen H, Ustunel M, Bilinc H, Gencer M, Buyukhatipoglu H. Evaluation of oxidative stress parameters and urinary deoxypyridinoline levels in geriatric patients with osteoporosis. J Phys Ther Sci 2014;26:1405-9.
14.    Ulas T, Dal MS, Demir ME, Buyukhatipoglu H. Comment on: oxidative stress in erythrocytes from patients with rheumatoid arthritis. Rheumatol Int 2014;34:293
15.    Kuzhan A, Adli M, Buyukhatipoglu H. Influence of ethnicity on survival of breast cancer patients in Turkey. Asian Pac J Cancer Prev 2014;15:9199-202. 
16.    Suner A, Buyukhatipoglu H, Balakan O, Kalender ME, Ulas T, Sevinc A, Camci C. Importance of HER2 Work-Up and Treatment Even in Patients with Poor Performance Status: A Case Report. Case Rep Oncol Med 2014;2014:731581. 
17.    Ulas T, Dal MS, Tursun I, Demir ME, Buyukhatipoglu H. Comment on: acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol 2013;50:825-6. 
18.    Ulas T, Hacibekiroglu T, Sezen H, Buyukhatipoglu H. Comment on: Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2 deoxyguanosine and biopyrrin in atrial fibrillation: effect of sinus rhythm restoration. Int J Cardiol 2013; 47: 471-2.
19.    Ulas T, Buyukhatipoglu H, Kirhan I, Dal MS, Ulas S, Demir ME, Eren MA, Ucar M, Hazar A, Kurkcuoglu IC, Aksoy N. Evaluation of oxidative stress parameters and metabolic activities of nurses working day and night shifts. Rev Esc Enferm USP 2013;47:471-6.
20.    Ulas T, Tursun I, Demir ME, Dal MS, Buyukhatipoglu H. Comment on: infusion of lin-/sca-1+ and endothelial progenitor cells improves proinflammatory and oxidative stress markers in atherosclerotic mice. Int J Cardiol 2013;164:128.
21.    Ulas T, Buyukhatipoglu H, Dal MS, Kirhan I, Kaya Z, Demir ME, Tursun I, Eren MA, Aydogan T, Sezen Y, Aksoy N. Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions. J Res Med Sci 2013;18:205-9. 
22.    Ulas T, Tursun I, Dal MS, Buyukhatipoglu H. Comment on: Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 2013;16:98.
23.    Ulas T, Tursun I, Dal MS, Demir ME, Buyukhatipoglu H. In which HOMA-IR value acceptable for sampling the patients with insulin resistance? Int J Cardiol 2013;162:133. 
24.    Demir ME, Ulas T, Dal MS, Eren MA, Aydogan H, Yalcin S, Camuzcuoglu A, Hilali NG, Aksoy N, Buyukhatipoglu H. Oxidative stress parameters and ceruloplasmin levels in patients with severe preeclampsia. Clin Ter 2013;164:e83-7.

25.    Ulas T, Tursun I, Dal MS, Eren MA, Buyukhatipoglu H. Rapid improvement of Henoch-Schonlein purpura associated with the treatment of Helicobacter pylori infection. J Res Med Sci 2012;17:1086-8.
26.    Pehlivan Y, Onat AM, Ceylan N, Turkbeyler IH, Buyukhatipoglu H, Comez G, Babacan T, Tarakcioglu M. Serum leptin, resistin and TNF-α levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis 2012;15:374-9. 
27.    Ulas T, Buyukhatipoglu H, Bes C, Dal MS, Hacıbekiroglu I, Apucu HG, Borlu F. Familial Mediterranean fever without cardinal symptoms and role of genetic screening. Reumatismo 2012;64:172-4. 
28.    Ulas T, Dal MS, Bes C, Borlu F, Buyukhatipoglu H. Comment on: Study of Oxidative stress in vitiligo. Indian J Clin Biochem 2012; 27:318.
29.    Ulas T, Dal MS, Bes C, Borlu F, Buyukhatipoglu H. An adult-onset still's disease with autoimmune thyroiditis. Mymensingh Med J 2012;21:570-2.
30.    Ulas T, Buyukhatipoglu H, Eren MA, Dal MS, Torun A, Aydogan T, Demir ME,Turan MN. Evaluation of sleeping energy expenditure using the SenseWear Armband in patients with overt and subclinical hypothyroidism. Clin Invest Med 2012;35:E126-31
31.    Ulas T, Buyukhatipoglu H, Kirhan I, Dal MS, Eren MA, Hazar A, Demir ME, Aydogan T, Karababa F, Uyanikoglu A, Kurkcuoglu IC. The effect of day and night shifts on oxidative stress and anxiety symptoms of the nurses. Eur Rev Med Pharmacol Sci 2012;16:594-9. 
32.    Tiryaki O, Usalan C, Buyukhatipoglu H, Sayiner ZA, Kilisli H. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients. Clin Exp Hypertens 2012;34:145-52. 
33.    Ulas T, Dal MS, Demir ME, Buyukhatipoglu H. Comment on "Glutathione peroxidase activity in obese and nonobese diabetic patients and role of hyperglycemia in oxidative stress". J Midlife Health 2012;3:52
34.    Ulas T, Dal MS, Demir ME, Buyukhatipoglu H. Comment on "Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease". Pol Arch Med Wewn 2012;122:306. 
35.    Buyukhatipoglu H, Buyukaslan H, Pehlivan Y, Ceylan N, Ulas T, Tarakcioglu M, Onat AM. Increased urotensin-II activity in patients with Raynaud's phenomenon and systemic lupus erythematosus. Int J Rheum Dis 2011;14:276-81.
36.    Atik B, Erkutlu I, Tercan M, Buyukhatipoglu H, Bekerecioglu M, Pence S. The effects of exogenous melatonin on peripheral nerve regeneration and collagen formation in rats. J Surg Res 2011;166:330-6. 
37.    Akarsu E, Buyukhatipoglu H, Aktaran S, Kurtul N. Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves'ophthalmopathy. Clin Endocrinol 2011;74:118-24
38.    Buyukhatipoglu H, Kirhan I, Vural M, Taskin A, Sezen Y, Dag OF, Turan MN, Aksoy N. Oxidative stress increased in healthcare workers working 24-hour on-call shifts. Am J Med Sci 2010;340:462-7. 
39.    Buyukhatipoglu H, Sezen Y, Yildiz A, Kucukdurmaz Z, Faruk O. Hiccups as a sign of chronic myocardial ischemia. South Med J 2010;103:1184-5. 
40.    Buyukhatipoglu H, Sezen Y, Yildiz A, ve ark. Effects of statin use on total antioxidant capacity and ceruloplasmin activity. Clin Invest Med 2010;33:E313-20.
41.    Buyukhatipoglu H, Sezen Y, Yildiz A, Bas M, Kirhan I, Ulas T, Turan MN, Taskin A, Aksoy N. N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions. Pol Arch Med Wewn 2010;120:383-9.
42.    Sezen Y, Guntekin U, Iscan A, Kapakli H, Buyukhatipoglu H, Kucukdurmaz Z. Rapidly improving, severe, acute myocarditis after a scorpion bite: an extremely rare complication and successful management. Am J Emerg Med. 2010;28:844.e3-5
43.    Buyukhatipoglu H, Sezen Y, Guntekin U, Kirhan I, Dag OF. Acute renal failure with the combined use of rosuvastatin and fenofibrate. Ren Fail 2010;32:633-5. 
44.    Tiryaki O, Usalan C, Buyukhatipoglu H. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients. Nephrology (Carlton) 2010;15:211-5. 
45.    Sezen Y, Bas M, Polat M, Yildiz A, Buyukhatipoglu H, Kucukdurmaz Z, Kaya Z, Demirbag R. The relationship between oxidative stress and coronary artery ectasia. Cardiol J 2010;17:488-94. 
46.    Tiryaki O, Buyukhatipoglu H, Usalan C. Plasma plasminogen activator inhibitor 1 (PAI-1) and P-selectin levels in urgent hypertension: effect of single dose captopril and nifedipine on fibrinolytic activity. Clin Exp Hypertens 2010;32:347-51. 
47.    Sezen Y, Buyukhatipoglu H, Kucukdurmaz Z, Geyik R. Cardiovascular involvement in Behçet's disease. Clin Rheumatol 2010;29:7-12. Erratum in: Clin Rheumatol 2010;29:231. Buyukatipoglu, Hakan [corrected to Buyukhatipoglu, Hakan].
48.    Sezen Y, Bas M, Altiparmak H, Yildiz A, Buyukhatipoglu H, Faruk Dag O, Kaya Z, Aksoy N. Serum prolidase activity in idiopathic and ischemic cardiomyopathy patients. J Clin Lab Anal 2010;24:213-8. 
49.    Buyukhatipoglu H, Tiryaki O, Usalan C. Impaired fibrinolytic and blunted nitric oxide response to phlebotomy in cigarette smoking healthy blood donors. J Int Med Res 2009;37:674-9. 
50.    Kucukdurmaz Z, Buyukhatipoglu H, Sezen Y, Kaya Z. Polycystic kidney disease with coronary aneurysm and acute coronary syndrome. Intern Med 2009;48:1989-91. 
51.    Erkutlu I, Buyukhatipoglu H, Alptekin M, Berkyurek E, Tutar E, Gok A. Spinal drop metastases from a papillary meningioma: a case report and review of the literature: utility of CSF sampling. Med Oncol 2009;26:242-6. 
52.    Usalan C, Buyukhatipoglu H, Tiryaki O, Sahin A. Function of dynamically stimulated endothelium and renin angiotensin-aldosterone system in normotensive subjects with a family history of hypertension. Nephrology (Carlton) 2008;13:689-93. 
53.    Okan V, Yilmaz M, Bayram A, Kis C, Cifci S, Buyukhatipoglu H, Pehlivan M. Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders. Int J Hematol 2008;88:403-8. 
54.    Buyukhatipoglu H. A possibly overlooked side effect of Orlistat: gastroesophageal reflux disease. J Natl Med Assoc 2008;100:1207. 
55.    Buyukhatipoglu H, Pehlivan Y, Onat AM. Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology (Oxford) 2008;47:1438-9;author reply 1439-40. 
56.    Usalan C, Buyukhatipoglu H. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system. Clin Appl Thromb Hemost 2008;14:203-9. 
57.    Bekerecioglu M, Onat AM, Tercan M, Buyukhatipoglu H, Karakok M, Isik D, Bulut O. The association between silicone implants and both antibodies and autoimmune diseases. Clin Rheumatol 2008;27:147-50. 
58.    Buyukhatipoglu H, Tiryaki O, Tahta K, Usalan C. Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: the role of chlamydia and cytomegalovirus infection. Nephrology (Carlton)2007;12:25-32. 
59.    Tutar E, Onat AM, Aydin A, Kervancioğlu S, Buyukhatipoglu H, Inan G, PehlivanY. Amyloid tumor of the breast mimicking breast carcinoma. South Med J 2008;101:199-201.
60.    Erkutlu I, Buyukhatipoglu H, Alptekin M, Gok A. Where is the brain paranchyme? "Primary cerebral multiple cyst hydatid". Intern Med 2008;47:333.
61.     Yilmaz M, Tiryaki O, Namiduru M, Okan V, Oguz A, Buyukhatipoglu H, Karaoglan I, Yilmaz B. Brucellosis-induced immune thrombocytopenia mimicking ITP: a report of seven cases. Int J Lab Hematol 2007;29:442-5
62.    Sevinc A, Camci C, Yilmaz M, Buyukhatipoglu H. The diagnosis of C-kit negative GIST by PDGFRA staining: clinical, pathological, and nuclear medicine perspective. Onkologie 2007;30:645-8. 
63.    Yilmaz M, Okan V, Pehlivan M, Ozkur A, Pehlivan Y, Buyukhatipoglu H, Sari I. A case report of POEMS syndrome developing during the clinical course of immune thrombocytopenic purpura. Platelets 2007;18:540-2. 
64.    Onat AM, Pehlivan Y, Buyukhatipoglu H, Igci YZ, Okumus S, Arikan C, Oguzkan S. Unusual presentation of triple A syndrome mimicking Sjögren's syndrome. Clin Rheumatol 2007;26:1749-51. 
65.    Erkutlu I, Buyukhatipoglu H, Alptekin M, Ozsarac C, Buyukbese I, Gok A. Primary spinal epidural extraosseous Ewing's sarcoma mimicking a spinal abscess. Pediatr Hematol Oncol 2007;24:537-42. 
66.    Buyukhatipoglu H, Pehlivan Y, Geyik R, Kadayifci A. Predictive role of H.pylori infection in functional dyspepsia. J Natl Med Assoc 2007;99:855. 
67.    Buyukhatipoglu H, Pehlivan Y, Geyik R, Camci C, Shandiz FH. Correlation does  not always show a causal relationship. Saudi Med J 2007;28:1462; author reply 1462

68.    Tiryaki O, Buyukhatipoglu H, Onat AM, Kervancioglu S, Cologlu S, Usalan. Takayasu arteritis: association with focal segmental glomerulosclerosis. Clin Rheumatol 2007;26:609-11. 
69.    Buyukhatipoglu H, Sevinc A, Pehlivan Y, Camci C. Is prophylactic cranial irradiation a possible option for human epidermal growth factor receptor 2-positive breast cancer? J Clin Oncol 2007;25:1292; author reply 1293. 
70.    Onat AM, Buyukhatipoglu H, Yilmaz M, Geyik R, Celik A, Ozturk MA. Immunoglobulin E: a new diagnostic clue for Behçet's disease? IgE and Behçet's disease. Clin Rheumatol 2007;26:81-3. 
71.    Usalan C, Buyukhatipoglu H, Tiryaki O. Systemic lupus erythematosus complicated by dilated cardiomyopathy and severe heart failure. Clin Rheumatol 2007;26:125-7. 
72.    Pehlivan Y, Toy MA, Karaoglan I, Namiduru M, Buyukhatipoglu H. Enterococcus avium cerebral abscess. Intern Med 2007;46:1280. 
73.    Tiryaki O, Buyukhatipoglu H, Karakok M, Usalan C. Successful treatment of a rare complication of Henoch-Schönlein purpura in advanced age: pulmonary hemorrhage. Intern Med 2007;46:905-7. 
74.    Karatas E, Onat AM, Durucu C, Baglam T, Kanlikama M, Altunoren O, Buyukhatipoglu H. Audiovestibular disturbance in patients with systemic lupus erythematosus. Otolaryngol Head Neck Surg 2007;136:82-6.
75.    Ovayolu N, Ucan O, Pehlivan S, Pehlivan Y, Buyukhatipoglu H, Savas MC, Gulsen MT. Listening to Turkish classical music decreases patients' anxiety, pain, dissatisfaction and the dose of sedative and analgesic drugs during colonoscopy: a prospective randomized controlled trial. World J Gastroenterol 2006;12:7532-6. 
76.    Ovayolu N, Torun S, Ucan O, Ozdemir P, Buyukhatipoglu H, Pehlivan Y, Geyik R. Review of data of the patients receiving total parenteral nutrition at the intensive care unit of a university hospital. J Natl Med Assoc 2006 ;98:1958-62. 
77.    Kadayifci A, Buyukhatipoglu H, Cemil Savas M, Simsek I. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006;28(11):1960-6. 
78.    Akarsu E, Buyukhatipoglu H, Aktaran S, Geyik R. The value of urine specific gravity in detecting diabetes insipidus in a patient with uncontrolled diabetes mellitus: urine specific gravity in differential diagnosis. J Gen Intern Med 2006;21:C1-2.
79.    Akarsu E, Buyukhatipoglu H, Aktaran S, Geyik R. Propylthiouracil-related hemorrhagic diathesis: a case report and review of the literature. Mt Sinai J Med 2006;73:1021-3. 
80.    Buyukhatipoglu H, Sevinc A, Camci C, Buyukberber S, Sari I. A case representing coexistence of acute myeloblastic leukemia and dedifferentiated liposarcoma: the possible role of chemotherapy in triggering dedifferentiation. Clin Lab Haematol 2006;28:343-6
81.    Yilmaz M, Camci C, Sari I, Okan V, Sevinc A, Onat AM, Buyukhatipoglu H. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto's disease) mimicking systemic lupus erythematosus: a review of two cases. Lupus 2006;15:384-7

•    Ulusal
1.    Akarsu E, Aktaran S, Buyukhatipoglu H, Oguz A. Dysarthria associated with Hashimoto's Disease in type 1 diabetic patient. Turkish Journal of Endocrinology and Metabolism 2004; 4:139-141.
2.    Yilmaz A, Kalender ME, Turk HC, Pehlivan Y, Buyukhatipoglu H, Sevinc A, Karakok M. Renal Hücreli Karsinom ve Kolon Adenokarsinom Birlikteliği. International Journal of Hematology and Oncology 2007;17:98-102.
3.    Sezen Y, Guntekin U, Yildiz A, Demirbag R, Bas M, Kucukdurmaz Z, Sezen H, Buyukaslan H, Buyukhatipoglu H, Taskin A, Celik H, Aksoy N. Serum katalaz enzim aktivitesi ile iskemik ve idyopatik dilate kardiyomiyopati varlığının ilişkisi.  MN Kardiyoloji 2010;3:172-179.
4.    Buyukhatipoglu H, Etkar I, Eren MA, Demir M, Taskin A, Aksoy N, "Hepatosteatoz hastalarında prolidaz enzim aktivitesi ile ultrasonografik evreleme arasındaki ilişki". Harran Üniversitesi Tıp Fakültesi Dergisi 2010;7: 54-57.
5.    Geyik R, Buyukhatipoglu H, Savas MC, Koruk M, Kadayifci A, "İmmünbağışık bir gebede gelişen fulminan herpes hepatiti ve ayırıcı tanıya yaklaşım", Harran Üniversitesi Tıp Fakültesi Dergisi 2010;7:68-69.
6.    Kucukdurmaz Z, Sezen Y, Yildiz S, Buyukhatipoglu H, "Two locations, two hits; two faces of the sword: co-existence of coronary and cerebral arterial aneurysms”, Eur J Gen Med 2011;8:236-237.
7.    Buyukhatipoglu H, Sezen Y, Yildiz A, Polat M, Demirbag R. De-novo arteriovenous fistula as a cause of secondary hypertension. EAJM 2010;42:164.
8.    Buyukhatipoglu H, Celik Y, Eren MA, Dag OF, Gencer M, Celik M, Aksoy N. Tip 2 Diyabetli Hastalarda Mikroalbüminüri ile Karbonmonoksit Difüzyon Kapasitesi Arasındaki İlişki.  Düzce Tıp Dergisi 2011;13:30-35.
9.    Vural M, Buyukhatipoglu H, Demirkol A, Uludag M. Possible relationship between infertility and alkaptonuria. Eur J Gen Med 2010;7:447-449.
10.    Vural M, Buyukhatipoglu H. Up to which limit one can survive with iron deficiency anemia. Journal of Clinical and Experimental Investigations. Clin Exp Invest 2010;1:226-227.
11.    Buyukhatipoglu H, Ulas T, Kirhan I, Demir M, Horoz M. İzole trombositopeni ile prezente olan brusellozis olgusu. Harran Üniversitesi Tıp Fakültesi Dergisi 2010;7:102-103.
12.    Ulas T, Kirhan I, Buyukhatipoglu H, Horoz M. Meyan kökü tüketimine bağlı hipokalemik kas güçsüzlüğü, parestezi ve ödem. Harran Üniversitesi Tıp Fakültesi Dergisi 2010;7:104-105

 
•    Türk Onkoloji Derneği
•    Türk Tabipler Birliği
•    American Society of Oncology
•    European Society of Oncology
•    European School of Oncology
 
Mezuniyet sertifikaları
•    Harvard Üniversitesi Moleküler Onkoloji 2018 
•    Harvard Üniversitesi Klinik Araştırmalar ve istatistik 2016 
•    Ulm Üniversitesi Meme kanseri yeterlilik 2015
•    Graduate of European school of Oncology 2019
Türk Onkoloji Derneği
•    Türk Tabipler Birliği
•    American Society of Oncology
•    European Society of Oncology
•    European School of Oncology
 

Uzmanına Sor / Görüntülü Görüşmeler ve Sağlık Hizmetleri Evinizde